GL1X · GenesisL1 explorer

MolNFT v1 · #6135 · protein

A new target for shigellosis: rational design and crystallographic studies of inhibitors of tRNA-guanine transglycosylase

1F3E · Queuine tRNA-ribosyltransferase: “A new target for shigellosis: rational design and crystallographic studies of inhibitors of tRNA-guanine…”. X-ray diffraction, 2 ligands (DPZ, ZN), 2 pockets (best druggability 0.66). MolNFT v1…

PDB
1F3E
Type
protein
Length
372 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Queuine tRNA-ribosyltransferase
EC
2.4.2.29
UniProt
P28720
Ligands
DPZ, ZN
Pockets
2 · best druggability 0.66

Structure

x-ray diffraction · 1 distinct chain · 45% helix, 19% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AQueuine tRNA-ribosyltransferase (EC 2.4.2.29)protein37245% helix, 19% strandP28720

Ligands and binding sites

  • DPZ · 3,5-diaminophthalhydrazide · ligand · chains A
  • ZN · Zinc ion · metal · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11870.660.8531DPZ
2740.360.7717empty

Compared structures

  • 1F3E · A new target for shigellosis: rational design and crystallographic studies of inhibitors… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.